Please use this identifier to cite or link to this item: http://theses.ncl.ac.uk/jspui/handle/10443/6288
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKirk, Cameron John-
dc.date.accessioned2024-09-30T13:21:34Z-
dc.date.available2024-09-30T13:21:34Z-
dc.date.issued2024-
dc.identifier.urihttp://hdl.handle.net/10443/6288-
dc.descriptionPhD Thesisen_US
dc.description.abstractA promising solution to the limited, clinical assessment of Parkinson’s (PD), has emerged through quantification of real-world walking speed (RWS) from wearable devices. RWS can be remotely assessed across consecutive days, measuring change in aspects of quality of life that are of importance to patients which can complement the existing clinical assessment of PD. The aims of this thesis were to address several gaps in the literature and explore, validate, and characterise RWS as a digital mobility outcome (DMO), to understand what complementary information it can provide to enhance the existing clinical assessment of mobility in PD. PD and older adults (OA) participants were recruited from two separate studies: the Incidence of Cognitive Impairment with Longitudinal Evaluation – GAIT (ICICLE-GAIT) and the Mobilise-D Technical Validation Study (TVS). Participants underwent mobility assessments in supervised and real-world environments over seven days, wearing a single lower-back wearable device. Algorithms were applied to estimate various macro and micro-level DMOs, including RWS within short, medium, and long walking bouts (WBs). In comparison to OAs, RWS was significantly slower in PD cross-sectionally and declined more rapidly longitudinally. At medium WBs, RWS was significantly related with MDS-UPDRS III score. In contrast to PD, OAs appeared to modulate their RWS differently between indoor and outdoor locations. Walking modulation was further characterised as three selected walking speeds, modelled as the number of modes within the distribution. Within short WBs, a larger number of selected walking speeds were associated with larger medication dosage and FOG score. This thesis provides evidence that digital assessment of RWS can provide novel complementary information about changes in gait that relate to real-world mobility and are of importance to patients. Inclusion of contextual data and novel statistical techniques can improve understanding of the impact of PD upon safe modulation of walking between different real-world scenarios and within a single bout of walking.en_US
dc.description.sponsorshipIMI, EU and European Federation of Pharmaceutical Industries and Associations, Parkinson’s UK and Newcastle Biomedical Research Centre.en_US
dc.language.isoenen_US
dc.publisherNewcastle Universityen_US
dc.titleDevelopment and validation of gait digital outcomes as clinical endpoints in Parkinson's Diseaseen_US
dc.typeThesisen_US
Appears in Collections:Translational and Clinical Research Institute

Files in This Item:
File Description SizeFormat 
Kirk C J 2024.pdf4.79 MBAdobe PDFView/Open
dspacelicence.pdf43.82 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.